Adverum Biotechnologies News

Adverum Biotechnologies | 8-K: Current report

Nov 18 16:11 ET

Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Vivo Opportunity Fund Holdings, L.P.(1.1%),Vivo Opportunity, LLC(1.1%)

Nov 14 19:01 ET

Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Logos Global Management LP(2.0%),Logos Global Management GP LLC(2.0%), etc.

Nov 14 18:46 ET

Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(0%),Commodore Capital Master LP(0%)

Nov 14 16:12 ET

Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(1.128%),Abigail P. Johnson(1.128%)

Nov 12 09:55 ET

Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)

Nov 8 14:27 ET

Adverum Biotechnologies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Morgan Stanley(0.4%),Morgan Stanley Capital Services LLC(0.1%)

Nov 6 17:52 ET

Adverum Biotechnologies | 10-Q: Q3 2024 Earnings Report

Nov 4 16:50 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones

Nov 4 16:45 ET

Adverum Biotechnologies | SCHEDULE 13G: Others

Oct 31 12:45 ET

Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Augustus Stern, MD(5.37%)

Oct 30 21:37 ET

Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Principia Wealth Advisory, LLC, EIN: 27-1545452(5.07%)

Oct 23 13:35 ET

Adverum Biotechnologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(7.2%)

Oct 22 18:10 ET

Adverum Biotechnologies | 10-Q: Q2 2024 Earnings Report

Aug 12 16:18 ET

Adverum Biotechnologies | 8-K: Adverum Biotechnologies Reports Second Quarter 2024 Financial Results and Provides Program and Corporate Highlights

Aug 12 16:12 ET

Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Soparkar Peter

Aug 6 16:18 ET

Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Seyedkazemi Setareh

Aug 6 16:18 ET

Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Rubinstein Linda M

Aug 6 16:18 ET

Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Fischer Laurent

Aug 6 16:16 ET

Adverum Biotechnologies | 4: Statement of changes in beneficial ownership of securities-Officer Ozden Rabia Gurses

Aug 6 16:13 ET